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Abstract
Background: Although World Health Organization guidelines recommend clinical judgment and chest radiography for
diagnosing tuberculosis in HIV-infected adults with unexplained cough and negative sputum smears for acid-fast bacilli, the
diagnostic performance of this approach is unknown. Therefore, we sought to assess the accuracy of symptoms, physical
signs, and radiographic findings for diagnosing tuberculosis in this population in a low-income country with a high
incidence of tuberculosis.
Methodology: We performed a cross-sectional study enrolling consecutive HIV-infected inpatients with unexplained cough
and negative sputum smears for acid-fast bacilli at Mulago Hospital in Kampala, Uganda. Trained medical officers
prospectively collected data on standard symptoms and signs of systemic respiratory illness, and two radiologists
interpreted chest radiographs in a standardized fashion. We calculated positive- and negative-likelihood ratios of these
factors for diagnosing pulmonary tuberculosis (defined when mycobacterial cultures of sputum or bronchoalveolar lavage
fluid were positive). We used both conventional and novel regression techniques to develop multivariable prediction
models for pulmonary tuberculosis.
Principal Findings: Among 202 enrolled HIV-infected adults with negative sputum smears for acid-fast bacilli, 72 (36%) had
culture-positive pulmonary tuberculosis. No single factor, including respiratory symptoms, physical findings, CD4+ T-cell
count, or chest radiographic abnormalities, substantially increased or decreased the likelihood of pulmonary tuberculosis.
After exhaustive testing, we were also unable to identify any combination of factors which reliably predicted
bacteriologically confirmed tuberculosis.
Conclusions and Significance: Clinical and radiographic criteria did not help diagnose smear-negative pulmonary
tuberculosis among HIV-infected patients with unexplained cough in a low-income setting. Enhanced diagnostic methods
for smear-negative tuberculosis are urgently needed.
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Introduction
The lack of accurate, rapid, inexpensive tests for the diagnosis of
pulmonary tuberculosis (TB) remains a major obstacle to effective
TB control, especially in high-burden countries in sub-Saharan
Africa where HIV co-infection is common. Sputum smear
microscopy, the standard diagnostic test for TB in low-income
countries, fails to diagnose about one-third to one-half of all TB
patients in systematic reviews. [1] Therefore, clinicians must either
use individual judgment to decide whether to treat empirically for
TB or to refer to a higher level of care without treatment.
Although both approaches are sanctioned by major international
guidelines [2,3], there are limited data on how well clinical and
radiographic factors perform for TB diagnosis in HIV-infected
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terial culture. [4,5] Since existing data may not apply to the
referral hospital setting envisaged in guidelines, we designed a
diagnostic cross-sectional study with two-month follow-up of HIV-
infected Ugandan adults with unexplained cough and negative
sputum smears for acid-fast bacilli (AFB). The objective of this
study was to identify routinely available clinical and/or radio-
graphic predictors or combinations of predictors with a strong
likelihood of diagnosing or excluding pulmonary TB.
Methods
Ethics Statement
The Makerere University Faculty of Medicine Research and
Ethics Committee, the Mulago Hospital Institutional Review
Board, the Committee on Human Research at the University of
California, San Francisco, and the Uganda National Council for
Science and Technology approved the protocol. Some of these
patients have been previously included in published studies.
[13,14,15]
Participants
During the period September 17, 2007–July 16, 2008, we
prospectively enrolled consecutive HIV-infected adult patients
admitted to the Medical Emergency Ward at Mulago National
Referral Hospital in Kampala, Uganda, with cough of $2 weeks
but ,6 months duration. We excluded patients with a history of
TB treatment in the previous two years, as well as those already
receiving anti-TB treatment. Each patient provided two sputum
samples for direct Ziehl-Neelsen light microscopy and Lowenstein-
Jensen mycobacterial culture, after a laboratory technician
provided standardized instructions on proper sputum submission.
[6] For this analysis, we excluded patients with a positive sputum
AFB smear.
Procedures
After written informed consent, a single medical officer (RK)
obtained demographic and clinical information from participants
in a standardized interview. The medical officer referred patients
for frontal chest radiography according to the hospital’s standard
protocol for evaluating patients suspected of TB, and digitally
photographed the films. Two board-certified radiologists (HK,
MK) who were blinded to all clinical and laboratory data reviewed
the digitized images according to a standardized interpretation
form, which was based on the previously validated Chest
Radiographic Reviewing and Reporting System. [7,8] The readers
involved a third radiologist (RO) to adjudicate whenever there
were differences in interpretation, and the differences were
resolved by consensus.
The study team referred patients for bronchoscopy with
bronchoalveolar lavage (BAL), which clinical investigators (WW,
SY, AC, JLD) performed according to a standardized protocol
that included airway inspection for Kaposi’s sarcoma lesions and
collection of BAL fluid. Trained microbiology technicians
analyzed BAL fluid by smear and culture for mycobacteria,
Pneumocystis, and other fungi according to standard protocols. Full
details of bronchoscopy and specimen examination are described
in the Online Supplement.
At discharge, we asked patients to return in two months for a
follow-up clinical examination and repeat sputum analysis. After
participants had completed all study procedures and the two-
month follow-up visit, at least two pulmonary physicians (AC,
JLD, LH, WW, and SY) reviewed all available clinical and
microbiologic data, and assigned final diagnoses according to
explicit clinical definitions (Online Supplement S1).
Statistical Analysis
We calculated risk ratios, sensitivities, specificities, and positive
and negative likelihood ratios to measure the performance of
clinical and radiographic variables for diagnosing TB, in reference
to a gold standard of any positive sputum or BAL fluid culture.
Although the sample size arose from convenience, we determined
the precision of all diagnostic accuracy estimates using exact
binomial confidence intervals in lieu of power calculations. [9] To
contrast the clinical utilities of clinical and radiographic factors for
either diagnosing or excluding TB, we categorized characteristics
as either predominantly ‘‘sensitive’’ or predominantly ‘‘specific.’’
We subjectively defined characteristics whose sensitivity estimates
were higher than their specificity estimates as ‘‘sensitive’’ tests, and
characteristics whose specificity estimates were higher than their
sensitivity estimates as ‘‘specific’’ tests.
To evaluate whether a combination of characteristics would be
highly predictive of TB, we constructed a multivariate model
including only the 14 factors with the greatest face validity in order
to optimize the balance between bias and variance. [10] We used
conventional logistic regression to generate predicted probabilities
of TB, plotted the fraction of true positives versus the fraction of
false positives at various thresholds of predicted probability as a
receiver operating characteristic curve, and measured model
accuracy using the concordance (C) statistic (area under the curve).
We adjusted our estimate of the C statistic for optimism using ten-
fold cross-validation with random re-sampling to generate average
predicted probabilities. [11] We investigated model misspecifica-
tion by examining the significance of added quadratic terms using
the Wald test, and we assessed model calibration using the
Hosmer-Lemeshow test. We performed several sensitivity analyses.
We assessed the impact of excluding patients who did not undergo
chest radiography by building a model based on clinical variables
only. Similarly, we re-ran our multivariate model including those
with unknown culture status, once assuming these individuals had
TB, and a second time assuming that they did not have TB. Last,
to test the vulnerability of our models to outcome misclassification,
we performed a sensitivity analysis in which we classified patients
with clinically defined culture-negative TB as having culture-
positive TB, and another in which we excluded these patients
entirely.
Finally, we built one additional multivariate model using the
Deletion/Substitution/Addition (DSA) algorithm [12], a novel
data-adaptive estimation routine that considers non-linear terms
and all possible interactions between predictors while simulta-
neously avoiding overfitting through repeated cross-validation. We
used STATA version 10.0 (Stata Corporation, College Station,




Of 407 patients enrolled, 251 (62%) were eligible for this
analysis by having negative sputum smears for AFB (Figure 1). The
other 156 patients had positive AFB smears, and 147 (94%) had
clinically and/or bacteriologically confirmed TB. Of the 251
smear-negative patients, 216 (86%) had chest radiography results.
Of the 35 sputum smear-negative patients missing chest
radiography results, one had an uninterpretable chest radiograph,
and 34 never underwent chest radiography, most commonly
because the radiology department was too busy at the time of
Smear-Negative TB Diagnosis
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the emergency ward. We excluded 14 additional subjects because
mycobacterial culture results were indeterminate (nine had both
sputum cultures contaminated and five could not produce a
respiratory specimen), leaving an eligible population of 202 HIV-
infected, sputum smear-negative patients with chest radiography
results. In addition, four patients with unknown CD4+ T-cell
counts were excluded from the DSA analysis.
As shown in Table 1, patients were generally young, with a
median age of 32 years (inter-quartile range (IQR) 28–39). Most
had advanced AIDS, with a median CD4+ T-cell count of
64 cells/mL (IQR 23–191). Although a high proportion (74%, 149
patients) had known of their HIV infection prior to admission,
only 18% (36 patients) were taking antiretroviral therapy. One-
hundred thirty-four (66%) patients had been treated with
antibiotics prior to admission without response. One-hundred
Figure 1. Patient enrollment and outcome flow diagram. The diagram presents the total numbers of patients enrolled, eligible, and analyzed,
and the vital status of all patients at two-month follow-up.
doi:10.1371/journal.pone.0009859.g001
Table 1. Demographic and clinical characteristics of the 202 study participants.
Characteristic All Patients TB* No TB P-value
(n=202) (n=72) (n=130)
Median age (IQR), years 32 (28–39) 32 (28–39) 33 (28–40) 0.59
Female sex (%) 113 (56) 38 (53) 75 (58) 0.50
Newly diagnosed with HIV (%) 53 (26) 14 (19) 39 (30) 0.10
Median CD4 count (IQR), cells/mL
{ 64 (23–191) 60 (17–148) 74 (26–213) 0.17
Taking co-trimoxazole prophylaxis (%)
" 117 (58) 48 (67) 69 (53) 0.061
Taking antiretroviral therapy (%)
1 36 (18) 15 (21) 21 (16) 0.41
Took antibiotics prior to admission (%) 134 (66) 51 (71) 83 (64) 0.31
Two-month mortality (%)
{ 58 (32) 27 (42) 31 (26) 0.028
Abbreviations: AFB, acid-fast bacilli; IQR, inter-quartile range; %, percent; TB, tuberculosis; mL, microliter.
Legend: *TB defined by any positive sputum or bronchoalveolar lavage mycobacterial culture on solid media.
{4 responses missing.
"All but one patient had been taking co-trimoxazole for $1 month.
1All patients reported taking antiretroviral therapy for $1 month.
{8 patients with TB and 12 patients without TB were lost to follow-up.
doi:10.1371/journal.pone.0009859.t001
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patients did not undergo bronchoscopy for the following reasons:
an alternate diagnosis was independently confirmed or the patient
improved on empiric therapy and was discharged (38, 19%); the
patient refused (23, 11%); or the patient was too ill or died before
the procedure (22, 11%).
Diagnoses and Outcomes
In 72 (36%) patients, sputum and/or BAL cultures were
positive for TB, and in 130 (64%) patients, they were negative.
Sixty-one (30%) patients were positive on both sputum and BAL
fluid cultures, and eleven (6%) were positive on BAL fluid
culture alone. Although their cultures were negative, 14% (29
patients, 18 with negative sputum and BAL fluid cultures and 11
with negative sputum cultures only) were classified as having
culture-negative TB, either because they improved with TB
treatment and had negative sputum cultures at the two-month
follow-up visit (16 patients, 8% ) ,o rb e c a u s et h e i rt w o - m o n t h
follow-up cultures were positive (13 patients, 6%). Of the
remaining 101 (50%) patients without a clinical or microbiologic
diagnosis of pulmonary TB, 59 (29%) patients had one or more
of the following diagnoses: 41 (20%) had bacterial pneumonia, 8
(4%) had cryptococcal pneumonia, 5 (2.5%) had Kaposi’s
sarcoma, 4 (2%) had Pneumocystis pneumonia, and 3 (1.5%) had
other non-infectious or extra-pulmonary explanations for their
symptoms. More than one diagnosis was present in two of these
59 patients (1%), and the final diagnosis was unknown in the
remaining 42 (21%) patients. Fifty-eight patients (32%) died
within two months of hospital admission, and 20 (10%) were lost
to follow-up. Those with culture-proven TB had a significantly
higher mortality at two months than non-TB patients (42% vs.
26%, Risk Ratio 1.6, 95% Confidence Interval (CI) 1.1–2.4,
p=0.028).
Individual Factors with a High Sensitivity or Specificity for
Tuberculosis
No individual clinical or radiographic factor was both sensitive
and specific for TB. Among individual symptoms, subjective fever,
weight loss, sputum production, and absence of hemoptysis were
more sensitive for TB than specific (Table 2). A CD4+ T-cell count
,200 cells/mL and chest radiography interpreted by a radiologist
as consistent with TB were also more sensitive for TB than
specific. Among all of these factors, weight loss (96%) and fever
(93%) had the highest sensitivities for TB.
In contrast, objective fever (body temperature $38.3uC) at the
time of evaluation was more specific than sensitive for TB
(Table 3). The radiographic presence of pleural effusion, cavities,
and hilar adenopathy were also more specific than sensitive for
TB. Among all of these factors, the presence of pleural effusion
(98%) and cavities (97%) had the highest specificities for TB.
Other clinical factors, including dyspnea, hypoxemia, tachy-
pnea, and abnormal breath sounds were neither sensitive nor
specific for TB. Except for objective fever, present in only 26 (13%)
patients, and absence of hemoptysis in 143 (71%) patients, no
clinical or radiographic factor achieved a positive or negative
likelihood ratio statistically different from 1.0, a value which
provides no diagnostic information. [16] Even after stratifying
patients by CD4+ T-cell count ($200 or ,200 cells/ul), there
were no characteristics which provided information that was
clinically useful for diagnosing or excluding TB.
Clinician Judgment
Forty-five (25%) of the 177 patients who survived to hospital
discharge were empirically started on standard TB treatment after
case review by National TB and Leprosy Control Programme
clinicians; sputum or BAL cultures turned positive for 23 (51%).
Table 2. Diagnostic performance of clinical and radiographic characteristics with high sensitivity for tuberculosis.
Characteristic Frequency TB* No TB Risk Ratio Sensitivity Specificity LR (+)L R ( 2)
(n=202) (%) (n=72) (n=130) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
History of fever 192 (95) 67 125 0.70 93 3.9 0.97 1.8
(0.36–1.3) (85–98) (1.3–8.8) (0.90–1.0) (0.54–6.0)
Weight loss 185 (92) 69 116 2.1 96 11 1.1 0.39
(0.74–6.0) (88–99) (6.0–17) (1.0–1.2) (0.12–1.3)
Sputum production 171 (85) 60 111 0.91 83 15 0.98 1.1
(0.56–1.5) (73–91) (9.0–22) (0.86–1.1) (0.59–2.2)
Absence of hemoptysis 143 (71) 58 85 1.7 81 35 1.2 0.56
(1.0–2.8) (70–89) (27–44) (1.0–1.5) (0.33–0.95)
Dyspnea 118 (58) 37 81 0.75 51 38 0.83 1.3
(0.52–1.1) (39–63) (29–47) (0.64–1.1) (0.93–1.8)
Abnormal breath sound 143 (71) 49 94 0.88 68 28 0.94 1.2
(0.59–1.3) (56–79) (20–36) (0.78–1.1) (0.75–1.8)
CD4 count ,200 cells/mL
{ 151 (76) 57 94 1.4 81 27 1.1 0.70
(0.82–2.3) (70–90) (19–35) (0.95–1.3) (0.40–1.2)
Radiologist’s diagnosis of TB 157 (78) 56 101 1.0 78 22 1.0 1.0
(0.64–1.6) (66–87) (16–30) (0.86–1.2) (0.58–1.7)
Abbreviations: 95% CI, 95% Confidence Interval; LR(+), positive likelihood ratio; LR (2), negative likelihood ratio; SD, standard deviation; TB, tuberculosis; %, percent;
mL, microliter.
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cultures turned positive for 40 (30%). The sensitivity of a clinician
decision to initiate TB treatment prior to hospital discharge was
37% (95% CI 25–50%) and specificity was 81% (95% CI 73–
88%), with a positive likelihood ratio of 1.9 (95% CI 1.2–3.1) and a
negative likelihood ratio of 0.79 (95% CI 0.64–0.97).
Multivariate Prediction Models
Wedeveloped a multivariableprediction model by regressing allof
the aforementioned clinical and radiographic variables on the log
odds of a positive mycobacterial culture. The model had acceptable
calibration (p=0.55 by the Hosmer-Lemeshow test) and was not
sensitive to outliers or model misspecification (p=0.40 by the Wald
test). As with the analyses of diagnostic accuracy for single variables, a
multivariate model including all 14 predictors found in Tables 2 and
3failedtoidentifyanylargeorstatisticallysignificantassociationswith
culture-positive TB. A receiver operating characteristic curve for this
combination of predictors (Figure 2) confirmed its poor clinical
performance (C statistic 0.67, 95% CI 0.59–0.75). Sensitivity analyses
incorporating patients with missing radiographic or culture results
into the model did not change the results across a full range of
assumptions. Similarly, neither reclassifying culture-negative TB
patients as having culture-positive TB nor excluding them from the
analysis changed any of these findings.
To test further the possibility that certain combinations of
variables from the full set of measured clinical and radiographic
predictors might be clinically useful for diagnosing TB, we
generated another prediction model using the Deletion/Substitu-
tion/Addition (DSA) routine. In examining 30 different clinical and
radiographic variables, no combination, with or without interaction
terms, outperformed a model including only the model intercept. In
other words, no clinical prediction rule could be identified that was
more accurate than randomly assigning diagnoses of TB in
proportion to the TB prevalence in the study population.
Discussion
Employing both conventional logistic regression and a novel
data-adaptive estimation routine, we failed to identify any clinical
or radiographic factor or combinations of factors with useful
performance characteristics for diagnosing TB among hospital-
ized, HIV-infected, smear-negative adults suspected of TB in a
low-income country with a high incidence of TB. Even a clinician
decision to initiate TB treatment at hospital discharge performed
only marginally better than chance. Among the 202 patients who
were fully evaluated for TB in accordance with World Health
Organization (WHO) guidelines for the assessment of smear-
negative patients in HIV-prevalent settings [2], one-third died
within two months of hospital admission. These findings
emphasize the need for studies of faster and more sensitive
diagnostic strategies for evaluating smear-negative patients,
including trials that measure the success of new diagnostics against
that of empiric treatment for TB in individuals at high risk of
death. [4]
Table 3. Diagnostic performance of clinical and radiographic characteristics with high specificity for tuberculosis.
Characteristic Frequency TB* No TB Risk Ratio Sensitivity Specificity LR (+)L R ( 2)
(n=202) (%) (n=72) (n=130) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Temperature $38.3uC 26 (13) 15 11 1.8 21 92 2.5 0.87
(1.2–2.6) (12–32) (85–96) (1.2–5.1) (0.76–0.98)
Respiratory rate $30 62 (31) 20 42 0.87 28 68 0.86 1.1
(0.57–1.3) (18–40) (59–76) (0.55–1.4) (0.89–1.3)
Oxygen saturation ,93% 53 (26) 19 34 1.0 26 74 1.0 1.0
(0.66–1.5) (17–38) (65–81) (0.62–1.6) (0.84–1.2)
Hilar adenopathy 31 (15) 10 21 0.89 14 84 0.86 1.0
(0.51–1.5) (6.9–24) (76–90) (0.43–1.7) (0.91–1.2)
Pleural effusion 26 (13) 12 14 1.4 17 89 1.6 0.93
(0.85–2.2) (8.9–27) (83–94) (0.76–3.2) (0.83–1.1)
Cavity 8 (4.0) 3 5 1.1 4.2 96 1.1 1.0
(0.42–2.6) (0.87–12) (91–99) (0.27–4.4) (0.94–1.1)
Abbreviations: 95% CI, 95% Confidence Interval; LR(+), positive likelihood ratio; LR (2), negative likelihood ratio; TB, tuberculosis; %, percent.
Legend: *TB defined by any positive sputum or bronchoalveolar lavage mycobacterial culture on solid media.
doi:10.1371/journal.pone.0009859.t003
Figure 2. Receiver operating characteristic (ROC) curve. The
sensitivity versus one minus the specificity of the cross-validated
multivariable logistic regression model for diagnosing tuberculosis
developed in this study is plotted at every threshold of probability of
tuberculosis predicted by the model.
doi:10.1371/journal.pone.0009859.g002
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factors, including the prevalence (or incidence) of the disease in the
population sample, the frequencies with which the test is positive in
patients with thedisease (sensitivity) and negativeinpatientswithout
the disease (specificity), and the physical risk and financial expense
associated with the test and any resulting treatment. Within this
framework, symptoms and physical findings are no different from
any other diagnostic test: characteristics subjectively defined as
sensitive are useful in excluding disease, especially when the disease
is uncommon in the population tested; and characteristics
subjectively defined as specific are useful in diagnosing disease,
especiallywhen the disease is commonin the populationtested.[17]
Given the comparatively low cost and low risks of using symptoms,
physical findings, and even chest radiography to diagnose TB, these
tests hold natural appeal to clinicians practicing in a high TB-
incidence, low-income country like Uganda—particularly since no
other tests are routinely available. Combining the information given
by sensitivity and specificity, positive likelihood ratios .2a n d
negative likelihood ratios ,0.5 represent the minimal diagnostic
performanceneededto increaseordecrease the post-testprobability
of a given diagnosis by 15%, the minimal change in probability
likely to be clinically important. [16] By these standards, our data
suggest that, except for the rare finding of objective fever (present in
only 13%), the clinical characteristics we evaluated are neither
sensitive nor specific enough to change the likelihood of TB in an
individual patient.
There are a number of possible explanations why, in spite of
evidence in the literature from sub-Saharan Africa and other
settings [18,19,20], physical signs, symptoms, and radiographic
findings did not predict TB in our setting. First, although previous
studies included some HIV-infected patients [21], our study
included only HIV-infected patients, most of whom had advanced
AIDS. These patients are at high risk of other opportunistic
pulmonary conditions which may present in isolation or in
combination with bacterial and mycobacterial infections. The
similarity of symptoms, signs, and radiographic findings across this
etiological spectrum, especially when multiple conditions are
present, may reduce the specificity of classical findings for the
diagnosis of TB. Second, the high value of clinical and
radiographic factors for screening high-risk populations for TB
(‘‘active case finding’’) must be distinguished from their low value
in diagnosing symptomatic patients suspected of TB (‘‘passive case
finding’’). [22] For TB screening among HIV-infected populations
initiating antiretroviral therapy, for example, much evidence
supports the usefulness of clinical and/or radiographic character-
istics. [5,7,23,24,25] For evaluating symptomatic patients suspect-
ed of TB, clinical characteristics may be useful for triage of
coughing patients to more sensitive (chest radiography) [26] or
more specific (sputum smear microscopy; antibiotic trials) tests
[27,28,29], but investigators have been unable to find algorithms
that are both highly sensitive and highly specific for confirming
TB, either because proposed models had poor reproducibility in
cross-validation samples [30], or because model complexity
reduced ease of use. [31] Third, several studies have used non-
standard measures of diagnostic performance such as odds ratios
to report their findings [19,32,33,34,35], rather than appropriate
measures such as sensitivity, specificity, and likelihood ratios. Odds
ratios overestimate the performance of clinical and radiographic
factors because they do not differentiate between false-positive and
false-negative test results. In addition, even odds ratios that are
large in epidemiologic terms may not indicate high levels of
diagnostic accuracy. [36]
There were several strengths to the study. First, the study
enrolled consecutive HIV-infected patients suspected of TB who
had been found to have negative sputum AFB smears while
undergoing routine evaluation. Because sputum smear microscopy
fails to detect almost half of all TB cases, patients with negative
smears represent a highly relevant population for whom a number
of clinical guidelines have been developed. [2,3] Second, since
clinicians with routine experience caring for patients in the study
hospital performed all measurements, the accuracy of the clinical
and radiographic measurements likely reflects or exceeds that
found in everyday practice. Third, we used a variety of rigorous
and exhaustive model construction methods to search for any
possible clinical or radiographic algorithm that might be
predictive. This approach makes it unlikely that our study could
be falsely negative. Although other investigators have used similar
techniques to identify clinically accurate algorithms [25,31,37],
our use of advanced prediction methods with cross-validation
applies a relatively novel approach to diagnosing TB in
symptomatic patients in a low-income country with a high
prevalence of HIV, where the demand for such algorithms is the
greatest. Finally, we performed multiple sensitivity analyses to be
sure that misclassification of TB status did not affect the internal
validity of our findings.
There were several limitations to the study. First, we studied a
severely ill population of inpatients, most of whom had failed a
course of antibiotics prior to admission. Although our findings may
thus appear less relevant than those from outpatient settings, our
patients are likely representative of the referral population
envisaged in two relevant WHO guidelines. These recommend
that smear-negative patients suspected of TB who fail to improve
after empiric antibiotic treatment be referred to a ‘‘hospital [for]
further assessment by a more senior clinician’’ [3], with the
decision to treat for TB to be based on ‘‘clinical assessment.’’ [2]
Although our exclusion of some patients who were missing chest x-
rays–perhaps because they were more severely ill–may also be
considered a limitation, the proportion was small (14%), and a
secondary analysis looking at clinical factors alone with inclusion
of these patients also failed to identify any highly predictive factors
for diagnosing TB.
Second, although our gold standard rigorously included
multiple sputum and/or BAL fluid cultures, we may have
misclassified some culture-negative patients as not having TB.
However, our study also included two-month follow-up of all
patients, and we were able to determine that the overall
proportion (15%) of patients with culture-negative TB in our
study was small. Moreover, neither reclassifying nor leaving these
patients out of the analysis changed our conclusions. Third, our
sample size may have been inadequate to generate an adequate
prediction model. However, the precision estimates for all
diagnostic performance measures (accuracy, likelihood ratios,
and the area under the receiver operating characteristic curve)
show that even a larger sample is unlikely to identify variables
which are clinically informative for diagnosing TB. Finally, it may
be impossible to divide the diagnostic value of a clinical impression
into discrete variables. Highly experienced and skilled clinicians
may be able to incorporate clinical and radiographic factors to
diagnose TB accurately in a manner that cannot be captured in
our analyses. However, we found that clinicians routinely
practicing in this setting were also unable to predict TB, as judged
by the low predictive value of their decisions to initiate TB
treatment in this study. Thus, while clinical and radiographic
algorithms may be appropriate for screening patients for TB in
settings with access to specific confirmatory tests such as culture,
the results of this and other operational studies argue against their
use for routine diagnosis of symptomatic, HIV-infected, smear-
negative patients suspected of TB. Instead, researchers and policy
Smear-Negative TB Diagnosis
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smear microscopy through streamlined sputum collection strate-
gies [38,39], light-emitting diode fluorescence imaging [40,41],
and improved quality assurance. [42,43]
In conclusion, clinicians evaluating hospitalized HIV-infected,
AFB smear-negative TB suspects face a tremendous challenge in
determining the causes of respiratory complaints in these patients.
For patients who lack danger signs, including tachypnea,
tachycardia, fever, and inability to walk, guidelines recommend
expert opinion in determining whether to initiate TB treatment.
[2] Our findings suggest that discrete clinical or radiographic
criteria are poorly predictive of culture-proven TB in a population
in which advanced AIDS is highly prevalent. In addition, the
exceptionally high early mortality among TB patients (42% at two
months) emphasizes the urgent need for diagnostic methods for
smear-negative TB which are more accurate than clinical criteria
yet equally rapid and affordable in low-income settings with a high
incidence of HIV and TB.
Supporting Information
Online Supplement S1 Supplementary details on research
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DOC)
Acknowledgments
The authors thank the patients who participated in this study, and the team
which enrolled them, including Florence Nankya, John Kiidha, Patrick
Byanyima, and Catherine Nabakiibi. We would also like to thank the
Mulago Hospital Administration for facilitating this research; the Infectious
Diseases Research Collaboration, including Professor Moses Kamya,
Catherine Tugaineyo, and Richard Oluga for their leadership and
administrative support; and Geoff Lavoy and Joseph Kasule, for their
assistance with data management. Finally, we acknowledge Bryan
Greenhouse for introducing us to novel prediction methods.
Author Contributions
Conceived and designed the experiments: JLD WW AC KP LH.
Performed the experiments: JLD HK MK RK RO SY. Analyzed the
data: JLD WW HK JZM AC MK RK SdB KP RO SY LH. Contributed
reagents/materials/analysis tools: JLD. Wrote the paper: JLD JZM LH.
References
1. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, et al. (2006) Sputum
processing methods to improve the sensitivity of smear microscopy for
tuberculosis: a systematic review. Lancet Infect Dis 6: 664–674.
2. World Health Organization (2006) Improving the diagnosis and treatment of
smear-negative pulmonary and extrapulmonary tuberculosis among adults and
adolescents. Recommendations for HIV-prevalent and resource-constrained
settings.
3. World Health Organization (2005) Integrated Management of Adult and
Adolescent Illness. A guideline for first-level facility health workers.
4. Wilson D, Nachega J, Morroni C, Chaisson R, Maartens G (2006) Diagnosing
smear-negative tuberculosis using case definitions and treatment response in
HIV-infected adults. Int J Tuberc Lung Dis 10: 31–38.
5. Were W, Moore D, Ekwaru P, Mwima G, Bunnell R, et al. (2009) A simple
screening tool for active tuberculosis in HIV-infected adults receiving
antiretroviral treatment in Uganda. Int J Tuberc Lung Dis 13: 47–53.
6. Khan MS, Dar O, Sismanidis C, Shah K, Godfrey-Faussett P (2007)
Improvement of tuberculosis case detection and reduction of discrepancies
between men and women by simple sputum-submission instructions: a
pragmatic randomised controlled trial. Lancet 369: 1955–1960.
7. Dawson R, Masuka P, Edwards DJ, Bateman ED, Bekker LG, et al. (2010) Chest
radiograph reading and recording system: evaluation for tuberculosis screening
in patients with advanced HIV. Int J Tuberc Lung Dis 14: 52–58.
8. den Boon S, Bateman ED, Enarson DA, Borgdorff MW, Verver S, et al. (2005)
Development and evaluation of a new chest radiograph reading and recording
system for epidemiological surveys of tuberculosis and lung disease. Int J Tuberc
Lung Dis 9: 1088–1096.
9. Cummings P, Rivara FP (2003) Reporting statistical information in medical
journal articles. Arch Pediatr Adolesc Med 157: 321–324.
10. Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable
in logistic and Cox regression. Am J Epidemiol 165: 710–718.
11. Harrell FE, Jr., Lee KL, Mark DB (1996) Multivariable prognostic models: issues
in developing models, evaluating assumptions and adequacy, and measuring and
reducing errors. Stat Med 15: 361–387.
12. Sinisi SE, van der Laan MJ (2004) Deletion/substitution/addition algorithm in
learning with applications in genomics. Stat Appl Genet Mol Biol 3: Article18.
13. Cattamanchi A, Davis JL, Worodria W, Yoo S, Matovu J, et al. (2008) Poor
performance of universal sample processing method for diagnosis of pulmonary
tuberculosis by smear microscopy and culture in Uganda. J Clin Microbiol 46:
3325–3329.
14. Cattamanchi A, Davis JL, Worodria W, den Boon S, Yoo S, et al. (2009)
Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary
tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis 13:
1130–1136.
15. Cattamanchi A, Dowdy DW, Davis JL, Worodria W, Yoo S, et al. (2009)
Sensitivity of direct versus concentrated sputum smear microscopy in HIV-
infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis 9:
53.
16. McGee S (2002) Simplifying likelihood ratios. J Gen Intern Med 17: 646–
649.
17. Newman T, Kohn M (2009) Evidence-Based Diagnosis. Cambridge: Cambridge
University Press.
18. Colebunders R, Bastian I (2000) A review of the diagnosis and treatment of
smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 4: 97–107.
19. Selwyn PA, Pumerantz AS, Durante A, Alcabes PG, Gourevitch MN, et al.
(1998) Clinical predictors of Pneumocystis carinii pneumonia, bacterial pneumonia
and tuberculosis in HIV-infected patients. AIDS 12: 885–893.
20. Kanaya AM, Glidden DV, Chambers HF (2001) Identifying pulmonary
tuberculosis in patients with negative sputum smear results. Chest 120: 349–355.
21. van Cleeff MR, Kivihya-Ndugga LE, Meme H, Odhiambo JA, Klatser PR
(2005) The role and performance of chest X-ray for the diagnosis of tuberculosis:
a cost-effectiveness analysis in Nairobi, Kenya. BMC Infect Dis 5: 111.
22. Reid MJ, Shah NS (2009) Approaches to tuberculosis screening and diagnosis in
people with HIV in resource-limited settings. Lancet Infect Dis 9: 173–184.
23. Mohammed A, Ehrlich R, Wood R, Cilliers F, Maartens G (2004) Screening for
tuberculosis in adults with advanced HIV infection prior to preventive therapy.
Int J Tuberc Lung Dis 8: 792–795.
24. Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, et al. (2009) Intensified
tuberculosis case finding among HIV-Infected persons from a voluntary
counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune
Defic Syndr 50: 537–545.
25. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, et al.
(2010) An algorithm for tuberculosis screening and diagnosis in people with
HIV. N Engl J Med 362: 707–716.
26. Harries AD, Kamenya A, Subramanyam VR, Maher D, Squire SB, et al. (1997)
Screening pulmonary tuberculosis suspects in Malawi: testing different strategies.
Trans R Soc Trop Med Hyg 91: 416–419.
27. Samb B, Henzel D, Daley CL, Mugusi F, Niyongabo T, et al. (1997) Methods
for diagnosing tuberculosis among in-patients in eastern Africa whose sputum
smears are negative. Int J Tuberc Lung Dis 1: 25–30.
28. Harries AD, Banda HT, Boeree MJ, Welby S, Wirima JJ, et al. (1998)
Management of pulmonary tuberculosis suspects with negative sputum smears
and normal or minimally abnormal chest radiographs in resource-poor settings.
Int J Tuberc Lung Dis 2: 999–1004.
29. Wilkinson D, Newman W, Reid A, Squire SB, Sturm AW, et al. (2000) Trial-of-
antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a
developing country with high HIV prevalence. Int J Tuberc Lung Dis 4:
513–518.
30. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, et al. (1999) The validity
of medical history, classic symptoms, and chest radiographs in predicting
pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction
model. Chest 115: 1248–1253.
31. El-Solh AA, Hsiao CB, Goodnough S, Serghani J, Grant BJ (1999) Predicting
active pulmonary tuberculosis using an artificial neural network. Chest 116:
968–973.
32. Samb B, Sow PS, Kony S, Maynart-Badiane M, Diouf G, et al. (1999) Risk
factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis:
results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc
Lung Dis 3: 330–336.
Smear-Negative TB Diagnosis
PLoS ONE | www.plosone.org 7 March 2010 | Volume 5 | Issue 3 | e985933. Bock N, McGowan J, Jr., Ahn J, Tapia J, Blumberg H (1996) Clinical predictors
of tuberculosis as a guide for a respiratory isolation policy. Am J Respir Crit
Care Med 154: 1468–1472.
34. Wisnivesky JP, Kaplan J, Henschke C, McGinn TG, Crystal RG (2000)
Evaluation of Clinical Parameters to Predict Mycobacterium tuberculosis in
Inpatients. Arch Intern Med 160: 2471–2476.
35. Bakari M, Arbeit RD, Mtei L, Lyimo J, Waddell R, et al. (2008) Basis for
treatment of tuberculosis among HIV-infected patients in Tanzania: the role of
chest x-ray and sputum culture. BMC Infect Dis 8: 32.
36. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of
the odds ratio in gauging the performance of a diagnostic, prognostic, or
screening marker. Am J Epidemiol 159: 882–890.
37. El-Solh A, Mylotte J, Sherif S, Serghani J, Grant BJ (1997) Validity of a decision
tree for predicting active pulmonary tuberculosis. Am J Respir Crit Care Med
155: 1711–1716.
38. Bonnet M, Ramsay A, Gagnidze L, Githui W, Guerin PJ, et al. (2007) Reducing
the number of sputum samples examined and thresholds for positivity: an
opportunity to optimise smear microscopy. Int J Tuberc Lung Dis 11: 953–958.
39. Steingart KR, Ramsay A, Pai M (2007) Optimizing sputum smear microscopy
for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther 5:
327–331.
40. Marais BJ, Brittle W, Painczyk K, Hesseling AC, Beyers N, et al. (2008) Use of
light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum.
Clin Infect Dis 47: 203–207.
41. Van Deun A, Chonde TM, Gumusboga M, Rienthong S (2008) Performance
and acceptability of the FluoLED Easy module for tuberculosis fluorescence
microscopy. Int J Tuberc Lung Dis 12: 1009–1014.
42. Cambanis A, Ramsay A, Wirkom V, Tata E, Cuevas LE (2007) Investing time in
microscopy: an opportunity to optimise smear-based case detection of
tuberculosis. Int J Tuberc Lung Dis 11: 40–45.
43. Shea YR, Davis JL, Huang L, Kovacs JA, Masur H, et al. (2009) High sensitivity
and specificity of acid-fast microscopy for diagnosis of pulmonary tuberculosis in
an African population with a high prevalence of human immunodeficiency virus.
J Clin Microbiol 47: 1553–1555.
Smear-Negative TB Diagnosis
PLoS ONE | www.plosone.org 8 March 2010 | Volume 5 | Issue 3 | e9859